Brief: Orthofix Medical Q3 Sales USD 196.6 Million Vs. IBES Estimate USD 196.5 Million
07/11/2024 12:05
Nov 07 (Reuters) - Orthofix Medical Q3 adjusted EBITDA USD 19.2 million vs. IBES estimate USD 17.4 million. * Q3 gross margin 68.7%
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team